Abstract
Purinergic signaling is increasingly recognized to play a role during the generation of hyperexcitable networks in the brain. Among the purinergic receptors, the ionotropic ATP-gated P2X7 receptor has attracted particular attention as a possible drug target for epilepsy. P2X7 receptor expression is increased in the brain of experimental models of epilepsy and in patients and, P2X7 receptor antagonism modulates seizure severity and epilepsy development. To date, studies analyzing the role of the P2X7 receptor during epilepsy have mainly focused on temporal lobe epilepsy, the most common form of acquired epilepsy in adults which is particularly prone to drug refractoriness.
Animal models of seizures and epilepsy are an essential tool in the identification of novel anticonvulsive and antiepileptogenic drug targets and much data demonstrating a role for the P2X7 receptor during epilepsy have been obtained by using these models. The aim of the present book chapter is to provide a detailed description of two commonly used mouse models of temporal lobe epilepsy, which are the intra-amygdala kainic acid model of status epilepticus and the controlled cortical impact model of traumatic brain injury. This chapter concludes with a brief description of how these models can be used to investigate the impact of targeting the P2X7 receptor on acute seizures, epilepsy development and established epilepsy .
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Moshe SL, Perucca E, Ryvlin P, Tomson T (2015) Epilepsy: new advances. Lancet 385(9971):884–898. https://doi.org/10.1016/S0140-6736(14)60456-6
Thijs RD, Surges R, O’Brien TJ, Sander JW (2019) Epilepsy in adults. Lancet 393(10172):689–701. https://doi.org/10.1016/S0140-6736(18)32596-0
Scheffer IE, Berkovic S, Capovilla G, Connolly MB, French J, Guilhoto L, Hirsch E, Jain S, Mathern GW, Moshe SL, Nordli DR, Perucca E, Tomson T, Wiebe S, Zhang YH, Zuberi SM (2017) ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia 58(4):512–521. https://doi.org/10.1111/epi.13709
Klein P, Dingledine R, Aronica E, Bernard C, Blumcke I, Boison D, Brodie MJ, Brooks-Kayal AR, Engel J Jr, Forcelli PA, Hirsch LJ, Kaminski RM, Klitgaard H, Kobow K, Lowenstein DH, Pearl PL, Pitkanen A, Puhakka N, Rogawski MA, Schmidt D, Sillanpaa M, Sloviter RS, Steinhauser C, Vezzani A, Walker MC, Loscher W (2018) Commonalities in epileptogenic processes from different acute brain insults: do they translate? Epilepsia 59(1):37–66. https://doi.org/10.1111/epi.13965
Chang BS, Lowenstein DH (2003) Epilepsy. N Engl J Med 349(13):1257–1266. https://doi.org/10.1056/NEJMra022308
Bialer M, White HS (2010) Key factors in the discovery and development of new antiepileptic drugs. Nat Rev Drug Discov 9(1):68–82. https://doi.org/10.1038/nrd2997
Vezzani A, Bartfai T, Bianchi M, Rossetti C, French J (2011) Therapeutic potential of new antiinflammatory drugs. Epilepsia 52(Suppl 8):67–69. https://doi.org/10.1111/j.1528-1167.2011.03242.x
Vezzani A, Friedman A, Dingledine RJ (2013) The role of inflammation in epileptogenesis. Neuropharmacology 69:16–24. https://doi.org/10.1016/j.neuropharm.2012.04.004
Monif M, Reid CA, Powell KL, Smart ML, Williams DA (2009) The P2X7 receptor drives microglial activation and proliferation: a trophic role for P2X7R pore. J Neurosci 29(12):3781–3791. https://doi.org/10.1523/JNEUROSCI.5512-08.2009
Sperlagh B, Illes P (2014) P2X7 receptor: an emerging target in central nervous system diseases. Trends Pharmacol Sci 35(10):537–547. https://doi.org/10.1016/j.tips.2014.08.002
Kopp R, Krautloher A, Ramirez-Fernandez A, Nicke A (2019) P2X7 interactions and signaling—making head or tail of it. Front Mol Neurosci 12:183. https://doi.org/10.3389/fnmol.2019.00183
Surprenant A, Rassendren F, Kawashima E, North RA, Buell G (1996) The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 272(5262):735–738. https://doi.org/10.1126/science.272.5262.735
Beamer E, Conte G, Engel T (2019) ATP release during seizures—a critical evaluation of the evidence. Brain Res Bull 151:65–73. https://doi.org/10.1016/j.brainresbull.2018.12.021
Dona F, Ulrich H, Persike DS, Conceicao IM, Blini JP, Cavalheiro EA, Fernandes MJ (2009) Alteration of purinergic P2X4 and P2X7 receptor expression in rats with temporal-lobe epilepsy induced by pilocarpine. Epilepsy Res 83(2–3):157–167. https://doi.org/10.1016/j.eplepsyres.2008.10.008
Jimenez-Pacheco A, Mesuret G, Sanz-Rodriguez A, Tanaka K, Mooney C, Conroy R, Miras-Portugal MT, Diaz-Hernandez M, Henshall DC, Engel T (2013) Increased neocortical expression of the P2X7 receptor after status epilepticus and anticonvulsant effect of P2X7 receptor antagonist A-438079. Epilepsia 54(9):1551–1561. https://doi.org/10.1111/epi.12257
Jimenez-Pacheco A, Diaz-Hernandez M, Arribas-Blazquez M, Sanz-Rodriguez A, Olivos-Ore LA, Artalejo AR, Alves M, Letavic M, Miras-Portugal MT, Conroy RM, Delanty N, Farrell MA, O’Brien DF, Bhattacharya A, Engel T, Henshall DC (2016) Transient P2X7 receptor antagonism produces lasting reductions in spontaneous seizures and gliosis in experimental temporal lobe epilepsy. J Neurosci 36(22):5920–5932. https://doi.org/10.1523/JNEUROSCI.4009-15.2016
Engel T, Jimenez-Pacheco A, Miras-Portugal MT, Diaz-Hernandez M, Henshall DC (2012) P2X7 receptor in epilepsy; role in pathophysiology and potential targeting for seizure control. Int J Physiol Pathophysiol Pharmacol 4(4):174–187
Kim JE, Kang TC (2011) The P2X7 receptor-pannexin-1 complex decreases muscarinic acetylcholine receptor-mediated seizure susceptibility in mice. J Clin Invest 121(5):2037–2047. https://doi.org/10.1172/JCI44818
Rozmer K, Gao P, Araujo MGL, Khan MT, Liu J, Rong W, Tang Y, Franke H, Krugel U, Fernandes MJS, Illes P (2017) Pilocarpine-induced status epilepticus increases the sensitivity of P2X7 and P2Y1 receptors to nucleotides at neural progenitor cells of the juvenile rodent hippocampus. Cereb Cortex 27(7):3568–3585. https://doi.org/10.1093/cercor/bhw178
Amhaoul H, Ali I, Mola M, Van Eetveldt A, Szewczyk K, Missault S, Bielen K, Kumar-Singh S, Rech J, Lord B, Ceusters M, Bhattacharya A, Dedeurwaerdere S (2016) P2X7 receptor antagonism reduces the severity of spontaneous seizures in a chronic model of temporal lobe epilepsy. Neuropharmacology 105:175–185. https://doi.org/10.1016/j.neuropharm.2016.01.018
Loscher W (2017) Animal models of seizures and epilepsy: past, present, and future role for the discovery of antiseizure drugs. Neurochem Res 42(7):1873–1888. https://doi.org/10.1007/s11064-017-2222-z
Kandratavicius L, Balista PA, Lopes-Aguiar C, Ruggiero RN, Umeoka EH, Garcia-Cairasco N, Bueno-Junior LS, Leite JP (2014) Animal models of epilepsy: use and limitations. Neuropsychiatr Dis Treat 10:1693–1705. https://doi.org/10.2147/NDT.S50371
Mouri G, Jimenez-Mateos E, Engel T, Dunleavy M, Hatazaki S, Paucard A, Matsushima S, Taki W, Henshall DC (2008) Unilateral hippocampal CA3-predominant damage and short latency epileptogenesis after intra-amygdala microinjection of kainic acid in mice. Brain Res 1213:140–151. https://doi.org/10.1016/j.brainres.2008.03.061
Mao X, Terpolilli NA, Wehn A, Cheng S, Hellal F, Liu B, Seker B, Plesnila N (2020) Progressive histopathological damage occurring up to one year after experimental traumatic brain injury is associated with cognitive decline and depression-like behavior. J Neurotrauma 37(11):1331–1341. https://doi.org/10.1089/neu.2019.6510
Schauwecker PE (2011) The relevance of individual genetic background and its role in animal models of epilepsy. Epilepsy Res 97(1–2):1–11. https://doi.org/10.1016/j.eplepsyres.2011.09.005
Araki T, Simon RP, Taki W, Lan JQ, Henshall DC (2002) Characterization of neuronal death induced by focally evoked limbic seizures in the C57BL/6 mouse. J Neurosci Res 69(5):614–621. https://doi.org/10.1002/jnr.10356
Shinoda S, Araki T, Lan JQ, Schindler CK, Simon RP, Taki W, Henshall DC (2004) Development of a model of seizure-induced hippocampal injury with features of programmed cell death in the BALB/c mouse. J Neurosci Res 76(1):121–128. https://doi.org/10.1002/jnr.20064
Conte G, Parras A, Alves M, Olla I, De Diego-Garcia L, Beamer E, Alalqam R, Ocampo A, Mendez R, Henshall DC, Lucas JJ, Engel T (2020) High concordance between hippocampal transcriptome of the mouse intra-amygdala kainic acid model and human temporal lobe epilepsy. Epilepsia 61(12):2795–2810. https://doi.org/10.1111/epi.16714
Engel T, Gomez-Villafuertes R, Tanaka K, Mesuret G, Sanz-Rodriguez A, Garcia-Huerta P, Miras-Portugal MT, Henshall DC, Diaz-Hernandez M (2012) Seizure suppression and neuroprotection by targeting the purinergic P2X7 receptor during status epilepticus in mice. FASEB J 26(4):1616–1628. https://doi.org/10.1096/fj.11-196089
Jimenez-Mateos EM, Arribas-Blazquez M, Sanz-Rodriguez A, Concannon C, Olivos-Ore LA, Reschke CR, Mooney CM, Mooney C, Lugara E, Morgan J, Langa E, Jimenez-Pacheco A, Silva LF, Mesuret G, Boison D, Miras-Portugal MT, Letavic M, Artalejo AR, Bhattacharya A, Diaz-Hernandez M, Henshall DC, Engel T (2015) microRNA targeting of the P2X7 purinoceptor opposes a contralateral epileptogenic focus in the hippocampus. Sci Rep 5:17486. https://doi.org/10.1038/srep17486
Jimenez-Mateos EM, Engel T, Merino-Serrais P, McKiernan RC, Tanaka K, Mouri G, Sano T, O’Tuathaigh C, Waddington JL, Prenter S, Delanty N, Farrell MA, O’Brien DF, Conroy RM, Stallings RL, DeFelipe J, Henshall DC (2012) Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects. Nat Med 18(7):1087–1094. https://doi.org/10.1038/nm.2834
Mesuret G, Engel T, Hessel EV, Sanz-Rodriguez A, Jimenez-Pacheco A, Miras-Portugal MT, Diaz-Hernandez M, Henshall DC (2014) P2X7 receptor inhibition interrupts the progression of seizures in immature rats and reduces hippocampal damage. CNS Neurosci Ther 20(6):556–564. https://doi.org/10.1111/cns.12272
Betjemann JP, Lowenstein DH (2015) Status epilepticus in adults. Lancet Neurol 14(6):615–624. https://doi.org/10.1016/S1474-4422(15)00042-3
Welzel L, Schidlitzki A, Twele F, Anjum M, Loscher W (2020) A face-to-face comparison of the intra-amygdala and intrahippocampal kainate mouse models of mesial temporal lobe epilepsy and their utility for testing novel therapies. Epilepsia 61(1):157–170. https://doi.org/10.1111/epi.16406
Bolkvadze T, Pitkanen A (2012) Development of post-traumatic epilepsy after controlled cortical impact and lateral fluid-percussion-induced brain injury in the mouse. J Neurotrauma 29(5):789–812. https://doi.org/10.1089/neu.2011.1954
Alves M, De Diego GL, Conte G, Jimenez-Mateos EM, D’Orsi B, Sanz-Rodriguez A, Prehn JHM, Henshall DC, Engel T (2019) Context-specific switch from anti- to pro-epileptogenic function of the P2Y1 receptor in experimental epilepsy. J Neurosci 39(27):5377–5392. https://doi.org/10.1523/JNEUROSCI.0089-19.2019
Fischer W, Franke H, Krugel U, Muller H, Dinkel K, Lord B, Letavic MA, Henshall DC, Engel T (2016) Critical evaluation of P2X7 receptor antagonists in selected seizure models. PLoS One 11(6):e0156468. https://doi.org/10.1371/journal.pone.0156468
Alves M, Kenny A, de Leo G, Beamer EH, Engel T (2019) Tau phosphorylation in a mouse model of temporal lobe epilepsy. Front Aging Neurosci 11:308. https://doi.org/10.3389/fnagi.2019.00308
Zhao F, Kang H, You L, Rastogi P, Venkatesh D, Chandra M (2014) Neuropsychological deficits in temporal lobe epilepsy: a comprehensive review. Ann Indian Acad Neurol 17(4):374–382. https://doi.org/10.4103/0972-2327.144003
Moran C, Sanz-Rodriguez A, Jimenez-Pacheco A, Martinez-Villareal J, McKiernan RC, Jimenez-Mateos EM, Mooney C, Woods I, Prehn JH, Henshall DC, Engel T (2013) Bmf upregulation through the AMP-activated protein kinase pathway may protect the brain from seizure-induced cell death. Cell Death Dis 4:e606. https://doi.org/10.1038/cddis.2013.136
Beamer EH, Jurado-Arjona J, Jimenez-Mateos EM, Morgan J, Reschke CR, Kenny A, de Leo G, Olivos-Ore LA, Arribas-Blazquez M, Madden SF, Merchan-Rubira J, Delanty N, Farrell MA, O’Brien DF, Avila J, Diaz-Hernandez M, Miras-Portugal MT, Artalejo AR, Hernandez F, Henshall DC, Engel T (2018) MicroRNA-22 controls aberrant neurogenesis and changes in neuronal morphology after status epilepticus. Front Mol Neurosci 11:442. https://doi.org/10.3389/fnmol.2018.00442
Lin JJ, Mula M, Hermann BP (2012) Uncovering the neurobehavioural comorbidities of epilepsy over the lifespan. Lancet 380(9848):1180–1192. https://doi.org/10.1016/S0140-6736(12)61455-X
Morgan J, Alves M, Conte G, Menendez-Mendez A, de Diego-Garcia L, de Leo G, Beamer E, Smith J, Nicke A, Engel T (2020) Characterization of the expression of the ATP-gated P2X7 receptor following status epilepticus and during epilepsy using a P2X7-EGFP reporter mouse. Neurosci Bull 36(11):1242–1258. https://doi.org/10.1007/s12264-020-00573-9
Rubin TG, Lipton ML (2019) Sex differences in animal models of traumatic brain injury. J Exp Neurosci 13:1179069519844020. https://doi.org/10.1177/1179069519844020
Hunt RF, Scheff SW, Smith BN (2009) Posttraumatic epilepsy after controlled cortical impact injury in mice. Exp Neurol 215(2):243–252. https://doi.org/10.1016/j.expneurol.2008.10.005
Hunt RF, Scheff SW, Smith BN (2010) Regionally localized recurrent excitation in the dentate gyrus of a cortical contusion model of posttraumatic epilepsy. J Neurophysiol 103(3):1490–1500. https://doi.org/10.1152/jn.00957.2009
Nelson DW, Gregg RJ, Kort ME, Perez-Medrano A, Voight EA, Wang Y, Grayson G, Namovic MT, Donnelly-Roberts DL, Niforatos W, Honore P, Jarvis MF, Faltynek CR, Carroll WA (2006) Structure-activity relationship studies on a series of novel, substituted 1-benzyl-5-phenyltetrazole P2X7 antagonists. J Med Chem 49(12):3659–3666. https://doi.org/10.1021/jm051202e
Donnelly-Roberts DL, Namovic MT, Han P, Jarvis MF (2009) Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors. Br J Pharmacol 157(7):1203–1214. https://doi.org/10.1111/j.1476-5381.2009.00233.x
Acknowledgments
This work was supported by funding from Science Foundation Ireland (17/CDA/4708), 2020 Government of Ireland Postdoctoral Fellowship Scheme (GOIPD/2020/865 and GOIPD/2020/806), and H2020 Marie Skłowdowksa-Curie Actions Individual Fellowship (project ID 796600).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Alves, M., de Diego-Garcia, L., Engel, T. (2022). Analyzing the Role of the P2X7 Receptor in Epilepsy. In: Nicke, A. (eds) The P2X7 Receptor. Methods in Molecular Biology, vol 2510. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2384-8_21
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2384-8_21
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2383-1
Online ISBN: 978-1-0716-2384-8
eBook Packages: Springer Protocols